301 related articles for article (PubMed ID: 9498745)
1. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
D'Orazio TJ; Niederkorn JY
J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
[TBL] [Abstract][Full Text] [Related]
2. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
3. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-gamma and induction of TGF-beta and IL-4 production.
Kosiewicz MM; Alard P; Streilein JW
J Immunol; 1998 Nov; 161(10):5382-90. PubMed ID: 9820512
[TBL] [Abstract][Full Text] [Related]
4. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
Wilbanks GA; Mammolenti M; Streilein JW
J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.
Maeda H; Shiraishi A
J Immunol; 1996 Jan; 156(1):73-8. PubMed ID: 8598496
[TBL] [Abstract][Full Text] [Related]
6. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
7. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
8. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
[TBL] [Abstract][Full Text] [Related]
9. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells.
Takeuchi M; Alard P; Streilein JW
J Immunol; 1998 Feb; 160(4):1589-97. PubMed ID: 9469414
[TBL] [Abstract][Full Text] [Related]
11. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis.
Ohta K; Yamagami S; Taylor AW; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2591-9. PubMed ID: 10937571
[TBL] [Abstract][Full Text] [Related]
12. The nature of antigen in the eye has a profound effect on the cytokine milieu and resultant immune response.
D'Orazio TJ; Niederkorn JY
Eur J Immunol; 1998 May; 28(5):1544-53. PubMed ID: 9603459
[TBL] [Abstract][Full Text] [Related]
13. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation.
Li XY; D'Orazio LT; Niederkorn JY
Immunology; 1996 Sep; 89(1):34-40. PubMed ID: 8911137
[TBL] [Abstract][Full Text] [Related]
14. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
Wilbanks GA; Streilein JW
Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
[TBL] [Abstract][Full Text] [Related]
15. Critical contribution of CD80 and CD86 to induction of anterior chamber-associated immune deviation.
Tsukahara R; Takeuchi M; Akiba H; Kezuka T; Takeda K; Usui Y; Usui M; Yagita H; Okumura K
Int Immunol; 2005 May; 17(5):523-30. PubMed ID: 15778288
[TBL] [Abstract][Full Text] [Related]
16. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
18. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.
Ferguson TA; Herndon JM; Dube P
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2643-51. PubMed ID: 8163352
[TBL] [Abstract][Full Text] [Related]
19. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
Kosiewicz MM; Streilein JW
J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M
J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
